# Guardion Health Sciences, Inc.

Guardion Health Sciences, Inc. is a company headquartered in Houston, TX, United States.

## Company overview

- **Legal name:** Guardion Health Sciences, Inc.
- **Former names in filing history:** Guardion Health Sciences, LLC (2015-05-18 to 2015-05-18)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Houston, TX, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001642375

## About

Guardion Health Sciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001642375, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-29, it reported annual revenue of USD 12,248,550; net income of USD 158,033; total assets of USD 11,918,177 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $12.2M (USD 12,248,550)
- **Net income:** $158,033 (USD 158,033)
- **Total assets:** $11.9M (USD 11,918,177)
- **Cash and equivalents:** $6.4M (USD 6,359,646)
- **Operating cash flow:** -$4.4M (USD -4,369,885)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $11.0M (USD 11,049,772)
- **Net income:** -$14.9M (USD -14,922,228)
- **Total assets:** $21.7M (USD 21,686,068)
- **Cash and equivalents:** $10.7M (USD 10,655,490)
- **Operating cash flow:** -$7.4M (USD -7,446,812)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $7.2M (USD 7,233,118)
- **Net income:** -$24.7M (USD -24,745,009)
- **Total assets:** $23.5M (USD 23,460,652)
- **Cash and equivalents:** $4.1M (USD 4,093,927)
- **Operating cash flow:** -$10.6M (USD -10,644,416)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $1.9M (USD 1,889,844)
- **Net income:** -$8.6M (USD -8,571,657)
- **Total assets:** $9.9M (USD 9,860,900)
- **Cash and equivalents:** $8.5M (USD 8,518,732)
- **Operating cash flow:** -$8.0M (USD -8,013,929)

## Recent SEC filings

- Form 8-K — filed 2024-12-26 — period 2024-12-23
- Form 8-K — filed 2024-11-18 — period 2024-11-14
- Form 8-K — filed 2024-10-31 — period 2024-10-30
- Form 8-K — filed 2024-10-03 — period 2024-10-01
- Form 8-K — filed 2024-09-23 — period 2024-09-17
- Form 8-K — filed 2024-08-21 — period 2024-08-21
- Form 8-K — filed 2024-08-14 — period 2024-08-13
- Form 10-Q — filed 2024-08-13 — period 2024-06-30
- Form 8-K — filed 2024-07-15 — period 2024-07-10
- Form 8-K — filed 2024-06-06 — period 2024-05-31
- Form 8-K — filed 2024-05-23 — period 2024-05-23
- Form 8-K — filed 2024-05-21 — period 2024-05-21

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/guardion-health-sciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology